DexCom
DXCM
DXCM
320 hedge funds and large institutions have $7.78B invested in DexCom in 2017 Q1 according to their latest regulatory filings, with 58 funds opening new positions, 100 increasing their positions, 123 reducing their positions, and 45 closing their positions.
Holders
320
Holders Change
+5
Holders Change %
+1.59%
% of All Funds
7.98%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
58
Increased
100
Reduced
123
Closed
45
Calls
$24.1M
Puts
$577M
Net Calls
-$553M
Net Calls Change
-$187M
Top Buyers
| 1 |
1
BlackRock
New York
|
$353M |
| 2 |
2
Bank of New York Mellon
New York
|
$216M |
| 3 |
SPC
3
Slate Path Capital
New York
|
$94.9M |
| 4 |
4
JPMorgan Chase & Co
New York
|
$80.9M |
| 5 |
5
Fidelity Investments
Boston,
Massachusetts
|
$834M |
